Biofilms on central venous catheters: Is eradication possible?

Current Topics in Microbiology and Immunology

Volumn 322, Issue , 2008, Pages 133-161

  Donlan, R M ^a  

^a NATIONAL CENTER FOR EMERGING AND ZOONOTIC INFECTIOUS DISEASES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMIKACIN; AMPHOTERICIN B; AMPICILLIN; AZTREONAM; CEFALOTIN; CEFAZOLIN; CEFTAZIDIME; CEFTRIAXONE; CIPROFLOXACIN; CLARITHROMYCIN; CLINDAMYCIN; DALFOPRISTIN PLUS QUINUPRISTIN; EPEREZOLID; ERYTHROMYCIN; FLUCONAZOLE; FOSFOMYCIN; GENTAMICIN; HEPARIN; IMIPENEM; LINEZOLID; MEZLOCILLIN; MINOCYCLINE; NAFCILLIN; NETILMICIN; RIFAMPICIN; ROXITHROMYCIN; TEICOPLANIN; TOBRAMYCIN; UNINDEXED DRUG; VANCOMYCIN; ANTIINFECTIVE AGENT;

ANTIBACTERIAL ACTIVITY; BACTEREMIA; BACTERIOPHAGE; BACTERIUM ISOLATION; BIOFILM; BLOODSTREAM INFECTION; CANDIDIASIS; CATHETER INFECTION; CENTRAL VENOUS CATHETER; DRUG MECHANISM; DRUG POTENTIATION; ENZYME DEGRADATION; ERADICATION THERAPY; HUMAN; IN VITRO STUDY; NONHUMAN; OUTCOME ASSESSMENT; PRIORITY JOURNAL; QUORUM SENSING; REVIEW; TREATMENT DURATION; TREATMENT OUTCOME; ULTRASOUND; URINARY TRACT INFECTION; ANIMAL; BACTERIAL INFECTION; CENTRAL VENOUS CATHETERIZATION; DISEASE MODEL; DRUG EFFECT; GROWTH, DEVELOPMENT AND AGING; INDWELLING CATHETER; MICROBIOLOGICAL EXAMINATION; MICROBIOLOGY;

ANIMALIA;

ANIMALS; ANTI-BACTERIAL AGENTS; BACTERIAL INFECTIONS; BIOFILMS; CATHETERIZATION, CENTRAL VENOUS; CATHETERS, INDWELLING; DISEASE MODELS, ANIMAL; HUMANS; MICROBIAL SENSITIVITY TESTS;

EID: 45549106144     PISSN: 0070217X     EISSN: None     Source Type: Book Series    
DOI: 10.1007/978-3-540-75418-3_7     Document Type: Review

References (105)

1. Ali-Abdi A, Mohammadi-Mehr M, Agha Alaei YA (2006) Bactericidal activity of various antibiotics against biofilm-producing Pseudmonas aeruginosa. Int J Antimicrob Agents 27:196-200
2. Alkawash MA, Soothill JS, Schiller NL (2006) Alginate lyase enhances antibiotic killing of mucoid Pseudomonas aeruginosa in biofilms. APMIS 114:131-138
3. Amorena B, Gracia E, Monzon M, Leiva J, Oteiza C, Perez M, Alabart J-L, Hernandez-Yago J (1999) Antibiotic susceptibility assay for Staphylococcus aureus in biofilms developed in vitro. J Antimicrob Chemother 44:43-55
4. Anaissie E, Samonis G, Kontoyiannis D, Costerton J, Sabharwal U, Bodey G, Raad I (1995) Role of catheter colonization and infrequent hematogenous seeding in catheter-related infections. Eur J Clin Microbiol Infect Dis 14:135-137
5. Andris DA, Krzywda EA, Edmiston CE, Krepel CJ, Gohr CM (1998) Elimination of intraluminal colonization by antibiotic lock in silicone vascular catheters. Nutrition 14:427-432
6. Anthony TU, Rubin LG (1999) Stability of antibiotics used for antibiotic-lock treatment of infections of implantable venous devices (ports). Antimicrob Agents Chemother 43:2074-2076
7. Anwar H, Strap JL, Chen K, Costerton JW (1992) Dynamic interactions of biofilms of mucoid Pseudomonas aeruginosa with tobramycin and pipercillin. Antimicrob Agents Chemother 36:1208-1214
8. Archibald L, Phillips L, Monnet D, McGowan JE Jr, Tenover F, Gaynes R (1997) Antimicrobial resistance in isolates from inpatients and outpatients in the United States: increasing importance of the intensive care unit. Clin Infect Dis 24:211-215
9. Aufwerber E, Ringertz S, Ransjo U (1991) Routine semiquantitative cultures and central venous catheter-related bacteremia. APMIS 99:627-630
10. Bachmann SP, Ramage G, VandeWalle K, Patterson TF, Wickes BL, Lopez-Ribot JL (2003) Antifungal combinations against Candida albicans biofilms in vitro. Antimicrob Agents Chemother 47:3657-3659
11. Bailey E, Berry N, Cheesbrough JS (2002) Antimicrobial lock therapy for catheter-related bacteraemia among patients on maintenance haemodialysis. J Antimicrob Chemother 50:611-618
12. Balaban N, Giacometti A, Cirioni O, Gov Y, Ghiselli R, Mocchegiani F, Viticchi C, Simona Del Prete M, Saba V, Scalise G, Dell'Acqua G (2003) Use of the quorum-sensing inhibitor RNAIII-Inhibiting peptide to prevent biofilm formation in vivo by drug-resistant Staphylococcus epidermidis. J Infect Dis 187:625-630
13. Balaban N, Stoodley P, Fux CA, Wilson S, Costerton JW, Dell'Acqua G (2005) Prevention of staphylococcal biofilm-associated infections by the quorum sensing inhibitor RIP. Clin Orthop Rel Res 437:48-54
14. Benoit J-L, Carandang G, Sitrin M, Annow PM (1995) Intraluminal antibiotic treatment of central venous catheter infections in patients receiving parenteral nutrition at home. Clin Infect Dis 21:1286-1288
15. Berrington A, Gould FK (2001) Use of antibiotic locks to treat colonized central venous catheters. J Antimicrob Chemother 48:597-603
16. Bjarnsholt T, Jensen PO, Rasmussen TB, Christophersen L, Calum H, Hentzer M, Hougen H-P, Rygaard J, Moser C, Eberl L, Hoiby N, Givskov M (2005) Garlic blocks quorum sensing and promotes rapid clearing of pulmonary Pseudomonas aeruginosa infections. Microbiology 151:3873-3880
17. Brun-Buisson C, Abrouk F, Legrand P, Huet Y, Larabi S, Rapin M (1987) Diagnosis of central venous catheter-related sepsis. Critical level of quantitative tip culture. Arch Intern Med 147:873-877
18. Capdevila JA, Segarra A, Planes AM, Ramirez-Arellano M, Pahissa A, Piera L, Martinez-Vazquez JM (1993) Successful treatment of haemodialysis catheter-related sepsis without catheter removal. Nephrol Dial Transplant 8:231-234
19. Capdevila JA, Gavalda J, Fortea J, Lopez P, Martin MT, Gomis X, Pahissa A (2001) Lack of antimicrobial activity of sodium heparin for treating experimental catheter-related infection due to Staphylococcus aureus using the antibiotic-lock technique. Clin Microbiol Infect 7:206-212
20. Carmen JC, Roeder BL, Nelson JL, Robison RL, Robison RA, Schaalje GB, Pitt WG (2005) Treatment of biofilm infections on implants with low-frequency ultrasound and antibiotics. Am J Infect Control 33:78-82
21. Centers for Disease Control and Prevention (1995) Recommendations for preventing the spread of vancomycin resistance: recommendations of the Hospital Infection Control Practices Advisory Committee (HICPAC). MMWR 44 (No. RR-12):1-13
22. Centers for Disease Control and Prevention (2002) Guidelines for prevention of intravascular catheter-related infections. MMWR 51 (No. RR-10):1-32
23. Ceri H, Olson ME, Stremick C, Read RR, Morck D, Buret A (1999) The Calgary Biofilm Device: new technology for rapid determination of antibiotic susceptibilities of bacterial biofilms. J Clin Microbiol 37:1771-1776
24. Chuard C, Vaudaux P, Waldvogel FA, Lew DP (1993) Susceptibility of Staphylococcus aureus growing on fibronectin-coated surfaces to bactericidal antibiotics. Antimicrob Agents Chemother 37:625-632
25. Curtin J, Cormican M, Fleming G, Keelehan J, Colleran E (2003) Linezolid compared with eperezolid, vancomycin, and gentamicin in an in vitro model of antimicrobial lock therapy for Staphylococcus epidermidis central venous catheter-related biofilm infections. Antimicrob Agents Chemother 47:3145-3148
26. Curtin JJ, Donlan RM (2006) Using bacteriophages to reduce formation of catheter-associated biofilms by Staphylococcus epidermidis . Antimicrob Agents Chemother 50:1268-1275
27. Darouiche RO, Raad II, Heard SO, Thornby JI, Wenker OC, Gabrielli A, Berg J, Khardori N, Hanna H, Hachem R, Harris R, Mayhall G (1999) A comparison of two antimicrobial-impregnated central venous catheters. N Engl J Med 340:1-8
28. Davies DG, Parsek MR, Pearson JP, Iglewski BH, Costerton JW, Greenberg EP (1998) The involvement of cell-to-cell signals in the development of a bacterial biofilm. Science 280:295-298
29. Domingue G, Ellis B, Dasgupta M, Costerton JW (1994) Testing antimicrobial susceptibilities of adherent bacteria by a method that incorporates guidelines of the National Committee for Clinical Laboratory Standards. J Clin Microbiol 32:2564-2568
30. Donlan RM (2001) Biofilm formation: a clinically relevant microbiological process. Clin Infect Dis 33:1387-1392
31. Donlan RM (2002) Biofilms: microbial life on surfaces. Emer Infect Dis 8:881-890
32. Donlan RM, Costerton JW (2002) Biofilms: survival mechanisms of clinically relevant microorganisms. Clin Microbiol Rev 15:167-193
33. Donlan RM, Murga R, Bell M, Toscano CM, Carr JH, Novicki TJ, Zuckerman C, Corey LC, Miller JM (2001) Protocol for detection of biofilms on needleless connectors attached to central venous catheters. J Clin Microbiol 39:750-753
34. Donlan RM, Piede JA, Heyes CD, Sanii L, Murga R, Edmonds P, El-Sayed I, El-Sayed MA (2004) Model system for growing and quantifying Streptococcus pneumoniae biofilms in situ and in real time. Appl Environ Microbiol 70:4980-4988
35. Doolittle MM, Cooney JJ, Caldwell DE (1995) Lytic infection of Escherichia coli biofilms by bacteriophage T4. Can J Microbiol 41:12-18
36. El-Azzi M, Rao S, Kanchanapoom T, Kardori N (2005) In vitro activity of vancomycin, quinupristin/dalfopristin, and linezolid against intact and disrupted biofilms of staphylococci. Ann Clin Microb Antimicrob 4:1-9
37. Elliott TSJ, Moss HA, Tebbs SE, Wilson IC, Bonser RS, Graham TR, Burke LP, Faroqui MH (1997) Novel approach to investigate a source of microbial contamination of central venous catheters. Eur J Clin Microbiol Infect Dis 16:210-213
38. Flowers RH, Schwenzer KJ, Kopel RF, Fisch MJ, Tucker SI, Farr BM (1989) Efficacy of an attachable subcutaneous cuff for the prevention of intravascular catheter-related infection. JAMA 261:878-883
39. Gagnon RF, Richards GK, Wiesenfeld L (1991) Staphylococcus epidermidis biofilms: unexpected outcome of double and triple antibiotic combinations with rifampin. ASAIO Trans 37:M158-M160
40. Gaillard J-L, Merlino R, Pajot N, Goulet O, Fauchere J-L, Ricour C, Vernon M (1990) Conventional and nonconventional modes of vancomycin administration to decontaminate the internal surface of catheters colonized with coagulase-negative staphylococci. JPEN J Paren Enteral Nutrit 14:593-597
41. Georgopapadakou NH, Walsh TJ (1994) Human mycoses: drugs and targets for emerging pathogens. Science 264:371-373
42. Giacometti A, Cirioni O, Ghisselli R, Orlando F, Mocchegiani F, Silvestri C, Licci A, De Fusco M, Provinciali M, Saba V, Scalise G (2005) Comparative efficacies of quinupristin-dalfopristin, linezolid, vancomycin, and ciprofloxacin in treatment, using the antibiotic-lock technique, of experimental catheter-related infection due to Staphylococcus aureus. Antimicrob Agents Chemother 49:4042-4045
43. Gordon CA, Hodges NA, Marriott C (1988) Antibiotic interaction and diffusion through alginate and exopolysaccharide of cystic fibrosis-derived Pseudomonas aeruginosa. J Antimicrob Chemother 22:667-674
44. Graybill JR (2001) The echinocandins, first novel class of antifungals in two decades: will they live up to their promise? Int J Clin Pract 55:633-638
45. Haimi-Cohen Y, Husain N, Meenan J, Karayaicin G, Lehrer M, Rubin LG (2001) Vancomycin and ceftazidime bioactivities persist for at least 2 weeks in the lumen in ports: simplifying treatment of port-associated bloodstream infections by using the antibiotic lock technique. Antimicrob Agents Chemother 45:1565-1567
46. Hanlon GW, Denyer SP, Olliff CJ, Ibrahim LJ (2001) Reduction of exopolysaccharide viscosity as an aid to bacteriophage penetration through Pseudomonas aeruginosa biofilms. Appl Environ Microbiol 67:2746-2753
47. Hatch RA, Schiller NL (1998) Alginate lyase promotes diffusion of aminoglycosides through the extracellular polysaccharide of mucoid Pseudomonas aeruginosa. Antimicrob Agents Chemother 42:974-977
48. +2-, and HEPES-treated Pseudomonas aeruginosa biofilms. Can J Microbiol 38:1214-1218
49. Hughes KA, Sutherland IW, Jones MV (1998) Biofilm susceptibility to bacteriophage attack: the role of phage-borne polysaccharide depolymerase. Microbiol 144:3039-3047
50. Johnson DC, Johnson FL, Goldman S (1994) Preliminary results treating persistent central venous catheter infections with the antibiotic lock technique in pediatric patients. Pediatr Infect Dis J 13:930-931
51. Johnson LL, Peterson RV, Pitt WG (1998) Treatment of bacterial biofilms on polymeric biomaterials using antibiotics and ultrasound. J Biomater Sci Polymer Edn 9:1177-1185
52. Kamal GD, Pfaller MA, Rempe, LE, Jebson PJR (1991) Reduced intravascular catheter infection by antibiotic bonding. A prospective, randomized, controlled trial. JAMA 265:2364-2368
53. Kandemir O, Oztuna V, Milcan A, Bayramoglu A, Celik, HH, Bayarslan C, Kaya A (2005) Clarithromycin destroys biofilms and enhances bactericidal agents in the treatment of Pseudomonas aeruginosa osteomyelitis. Clin Othop Rel Res 430:171-175
54. Kaplan AH, Gilligan PH, Facklam RR (1988) Recovery of resistant enterococci during vancomycin prophylaxis. J Clin Microbiol 26:1216-1218
55. Kite P, Eastwood K, Sugden S, Percival SL (2004) Use of in vivo-generated biofilms from hemodialysis catheters to test the efficacy of a novel antimicrobial catheter lock for biofilm eradication in vitro. J Clin Microbiol 42:3073-3076
56. Klevins RM, Tokars JI, Andrus M (2005) Nephrol News Issues 19:37-38, 43
57. Kowalewska-Grochowska K, Richards R, Moysa GL, Lam K, Costerton JW, King EG (1991) Guidewire catheter change in central venous catheter biofilm formation in a burn population. Chest 100:1090-1095
58. Kojic EM, Darouiche RO (2004) Candida infections of medical devices. Clin Microbiol Rev 17:255-267
59. Krzywda EA, Andris DA, Edmiston CE, Quebbeman EJ (1995) Treatment of Hickman catheter sepsis using antibiotic lock technique. Infect Control Hosp Epidemiol 16:596-598
60. Kucers A, Crowe SM, Grayson ML, Hoy JF (1997) The use of antibiotics: a clinical review of antibacterial, antifungal, and antiviral drugs, 5th edn, Butterworth-Heinemann, Oxford.
61. Kuhn DM, Chandra GT, Mukheree PK, Ghannoum MA (2002) Antifungal susceptibility of Candida biofilms: unique efficacy of Amphotericin B lipid formulations and Echinocandins. Antimicrob Agents Chemother 46:1773-1780
62. Lee J-Y, Ko KS, Peck KR, Oh WS, Song J-H (2006) In vitro evaluation of the antibiotic lock technique (ALT) for the treatment of catheter-related infections caused by staphylococci. J Antimicrob Chemother 57:1110-1115
63. Maki DG (1994) Infections caused by intravascular devices used for infusion therapy: pathogenesis, prevention, and management. In: Bisno AL, Waldvogel FA (eds) Infections associated with indwelling medical devices. American Society for Microbiology, Washington DC, pp 155-212
64. Maki DG, Stolz SM, Wheeler S, Mermel LA (1997) Prevention of central venous catheter-related bloodstream infection by use of an antiseptic- impregnated catheter. A randomized, controlled, trial. Ann Intern Med 127:257-266
65. Marr KA, Sexton DJ, Conlon PJ, Corey GR, Schwab SJ, Kirkland KB (1997) Catheter-related bacteremia and outcome of attempted catheter salvage in patients undergoing hemodialysis. Ann Inter Med 127:275-280
66. Mermel LA, Farr BM, Sheretz RJ, Raad II, O'Grady N, Harris JS, Craven DE (2001) Guidelines for the management of intravascular catheter-related infections. Clin Infect Dis 32:1249-1272
67. Messing B, Peitra-Cohen S, Debure A, Beliah M, Bernier J-J (1988) Antibiotic-lock technique: a new approach to optimal therapy for catheter-related sepsis in home-parenteral nutrition patients. JPEN J Paren Enteral Nutrit 12:185-189
68. Metcalf SCL, Chambers ST, Pithie AD (2004) Use of ethanol locks to prevent recurrent central line sepsis. J Infect 49:20-22
69. Monzon M, Oteiza C, Leiva J, Lamarta M, Amorena B (2002) Biofilm testing of Staphylococcus epidermidis clinical isolates: low performance of vancomycin in relation to other antibiotics. Diag Microbiol Infect Dis 44:319-324
70. Moreno CA, Rosenthal VD, Olarte N, Gomez WV, Sussmann O, Agudelo JG, Rojas C, Osorio L, Linares C, Valderrama A, Mercado PG, Bernate PH, Vergara GR, Pertuz AM, Mojica BE, Navarrete Mdel P, Romero AS, Henriquez D (2006) Device-associated infection rate and mortality in intensive care units of 9 Colombian hospitals: findings of the International Nosocomial Infection Control Consortium. Infect Control Hosp Epidemiol 27:349-356
71. Murga R, Miller JM, Donlan RM (2001) Biofilm formation by Gram-negative bacteria on central venous catheter connectors: effect of conditioning films in a laboratory model. J Clin Microbiol 39:2294-2297
72. Nichols WW, Evans MJ, Slack MPE, Walmsley HL (1989) The penetration of antibiotics into aggregates of mucoid and non-mucoid Pseudomonas aeruginosa. J Gen Microbiol 135:1291-1303
73. Pascual A, Ramirez de Arellano E, Perea EJ (1994) Activity of glycopeptides in combination with amikacin or rifampin against Staphylococcus epidermidis biofilms on plastic catheters. Eur J Clin Microbiol Infect Dis 13:515-517
74. Peck KR, Kim SW, Jung S-I, Kim Y-S, Oh WS, Lee JY, Jin JH, Kim S, Song J-H, Kobayashi H (2003) Antimicrobials as potential adjuctive agents in the treatment of biofilm infections with Staphylococcus epidermidis. Chemother 49:189-193
75. Percival SL, Kite P, Eastwood K, Murga R, Carr J, Arduino MJ, Donlan RM (2005) Tetrasodium EDTA as a novel central venous catheter lock solution against biofilm. Infect Control Hosp Epidemiol 26:515-519
76. Raad I (1998) Intravascular-catheter-related infections. Lancet 351:893-898
77. Raad I, Costerton JW, Sabharwal U, Sacilowski M, Anaissie W, Bodey GP (1993) Ultrastructural analysis of indwelling vascular catheters: a quantitative relationship between luminal colonization and duration of placement. J Infect Dis 168:400-407
78. Raad I, Buzaid A, Rhyne J, Hachem R, Darouiche R, Safar H, Albitar M, Sherertz RJ (1997) Minocycline and ethylenediaminetetraacetate for the prevention of recurrent vascular catheter infections. Clin Infect Dis 25:149-151
79. Raad I, Chatzinikolaou I, Chaiban G, Hanna H, Hachem R, Dvorak T, Cook G, Costerton W (2003) In vitro and ex vivo activities of minocycline and EDTA against microorganisms embedded in biofilm on catheter surfaces. Antimicrob Agents Chemother 47:3580-3585
80. Ramage G, VandeWalle K, Bachmann SP, Wickes BL, Lopez-Ribot JL (2002) In vitro pharmacodynamic properties of three antifungal agents against preformed Candida albicans biofilms determined by time-kill studies. Antimicrob Agents Chemother 46:3634-3636
81. Rao JS, O'Meara A, Harvey T, Breatnach F (1992) A new approach to the management of Broviac catheter infection. J Hosp Infect 22:109-116
82. Rasmussen TB, Bjarnsholt T, Skindersoe ME, Hentzer M, Kristoffersen P, Kote M, Nielsen J, Eberl L, Givskov M (2005) Screening for quorum-sensing inhibitors (QSI) by use of a novel genetic system, the QSI Selector. J Bacteriol 187:1799-1814
83. Rediske AM, Roeder BL, Brown MK, Nelson JL, Robison RL, Draper DO, Schaalje GB, Robison RA, Pitt WG (1999) Ultrasonic enhancement of antibiotic action on Escherichia coli biofilms: an in vivo model. Antimicrob Agents Chemother 43:1211-1214
84. Rice SA, McDougald D, Kumar N, Kjelleberg S (2005) The use of quorum-sensing blockers as therapeutic agents for the control of biofilm-associated infections. Curr Opin Investig Drugs 6:178-184
85. Richards GK, Gagnon RF, Prentis J (1991) Comparative rates of antibiotic action against Staphylococcus epidermidis biofilms. ASAIO Trans 37:M160-M162
86. Root JL, McIntyre R, Jacobs NJ, Daghlian CP (1988) Inhibitory effect of disodium EDTA upon the growth of Staphylococcus epidermidis in vitro: relation to infection prophylaxis of Hickman catheters. Antimicrob Agents Chemother 32:1627-1631.
87. Rupp ME, Ulphani JS, Fey PD, Mack D (1999) Characterization of Staphylococcus epidermidis polysaccharide intercellular adhesion/hemaglutinin in the pathogenesis of intravascular catheter-associated infection in a rate model. Infect Immun 67:2656-2659
88. Sandoe JAT, Wysome J, West AP, Heritage J, Wilcox MH (2006) measurement of ampicillin, vancomycin, linezolid, and gentamicin activity against enterococcal biofilms. J Antimicrob Chemother 57:767-770
89. Schinabeck MK, Long LA, Hossain MA, Chandra J, Mukherjee PK, Mohamed S, Ghannoum MA (2004) Rabbit model of Candida albicans biofilm infection: liposomal amphotericin B antifungal lock therapy. Antimicrob Agents Chemother 48:1727-1732
90. Schwalbe RS, Stapleton JT, Gilligan PH (1987). Emergence of vancomycin resistance in coagulase-negative staphylococci. N Eng J Med 316:927-931
91. Shah CB, Mittelman MW, Costerton JW, Parenteau S, Pelak M, Arsenault R, Mermel LA (2002) Antimicrobial activity of a novel catheter lock solution. Antimicrob Agents Chemother 46:1674-1679
92. Shinabarger DL, Marotti KR, Murray RW, Lin AH, Melchior EP, Swaney SM, Dunyak DS, Demyan WF, Buysse JM (1997) Mechanism of action of oxazolidinones: effects of linezolid and eperezolid on translation reactions. Antimicrob Agents Chemother 41:2132-2136
93. Sieradzki K, Leski T, Dick J, Borio L, Tomasz A (2003) Evolution of a vancomycin-intermediate Staphylococcus aureus strain in vivo: multiple changes in antibiotic resistance phenotypes of a single lineage of methicillin-resistant S. aureus under the impact of antibiotics administered for chemotherapy. J Clin Microbiol 41:1687-1693
94. Sillankova SR, Oliveira MJ, Vieira MJ, Sutherland IW, Azeredo J (2004) Bacteriophage Phi S1 infection of Pseudomonas fluorescens planktonic cells versus biofilms. Biofouling 20:133-138
95. Simon VC, Simon M (1990) Antibacterial activity of teicoplanin and vancomycin in combinations with rifampicin, fusidic acid or fosfomycin against staphylococci on vein catheters. Scan J Infect Dis Suppl 72:14-19
96. Souli M, Giamarellou H (1998) Effects of slime produced by clinical isolates of coagulase-negative staphylococci on activities of various antimicrobial agents. Antimicrob Agents Chemother 42:939-941
97. Stewart PS, Mukherjee PK, Ghannoum MA (2004) Biofilm antimicrobial resistance. In: Ghannoum M, O'Toole GA (eds) Microbial biofilms. ASM Press, Washington DC, pp 250-268
98. Stratton CW (2005) Molecular mechanisms of action for antimicrobial agents: general principles and mechanisms for selected classes of antibiotics. In: Lorian V (ed) Antibiotics in laboratory medicine. Lippincott, Williams, and Wilkins, Philadelphia, pp 532-536
99. Tenover FC (2001) Development and spread of bacterial resistance to antimicrobial agents: an overview. Clin Infect Dis 33 [Suppl 3]:S108-S115
100. Torres-Viera C, Thauvin-Eliopoulos C, Souli M, DeGirolami P, Farris MG, Wennersten CB, Sofia RD, Eliopoulos GM (2000) Activities of taurolidine in vitro and in experimental enterococcal endocarditis. Antimicrob Agents Chemother 44:1720-1724
101. Tresse O, Jouenne T, Junter G-A (1995) The role of oxygen limitation in the resistance of agarentrapped, sessile-like Escherichia coli to aminoglycoside and B-lactam antibiotics. J Antimicrob Chemother 36:521-526
102. Turakhia MH, Cooksey KE, Characklis WG (1983) Influence of a calcium-specific chelant on biofilm removal. Appl Environ Microbiol 46:1236-1238
103. Yamasaki O, Akiyama H, Toi Y, Arata J (2001) A combination of roxithromycin and imipenem as an antimicrobial strategy against biofilm formed by Staphylococcus aureus. J Antimicrob Chemother 48:573-577
104. Yasuda H, Ajiki Y, Koga T, Yokata T (1994) Interaction between clarithromycin and biofilms formed by Staphylococcus epidermidis. Antimicrob Agents Chemother 38:138-141
105. Zufferey J, Rime R, Francioli P, Bille J (1988) Simple method for rapid diagnosis of catheter-associated infection by direct acridine orange staining of catheter tips. J Clin Microbiol 26:175-177